ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: communication

The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

Steven M. Harris, Esq.  |  March 17, 2020

In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

Filed under:Legal UpdatesProfessional Topics Tagged with:COVID-19telehealthtelemedicine

FDA Update: New Drug Approvals, New & Expanded Indications, & More

Susan Bernstein  |  March 12, 2020

ATLANTA—New drug approvals, new and expanded drug indications, and important safety and other updates relevant for rheumatologists were presented by three physicians from the U.S. Food & Drug Administration (FDA) on Nov. 11 at the 2019 ACR/ARP Annual Meeting. New JAK Inhibitor Approved for RA On Aug. 16, 2019, the FDA approved upadacitinib (Rinvoq), an…

Filed under:Biologics/DMARDsDrug UpdatesMeeting Reports Tagged with:2019 ACR/ARP Annual MeetingapremilastCertolizumab PegolFebuxostatixekizumabJAK inhibitorsnintedanibrituximabU.S. Food and Drug Administration (FDA)upadacitinib

Physicians Identify Professional Dissonance as a Cause of Burnout

Lara C. Pullen, PhD  |  March 9, 2020

Recent research into burnout in primary care providers has found many providers experience professional dissonance and cite increasing paperwork and undervaluation as contributors to burnout. The study also outlined solutions that may improve professional fulfillment…

Filed under:Career DevelopmentProfessional Topics Tagged with:burnoutphysician burnoutprimary carePrimary Care Physicianwork-life balance

Data for Better Patient Care: As the RISE Registry Expands, So Do Its Ambitions

Thomas R. Collins  |  February 25, 2020

Learn what RISE has to offer and how it’s growing.

Filed under:Meeting Reports Tagged with:2019 ACR/ARP Annual MeetingRISE

15% E/M Services Reimbursement Hike a Win for Rheumatology

Carina Stanton  |  February 19, 2020

ACR advocacy leaders are celebrating a 15% planned increase in reimbursement for rheumatology evaluation and management services and are calling on members to thank Congress.

Filed under:Legislation & Advocacy Tagged with:evaluation and management (E/M) codesPhysician fee schedule

5 Challenges in the Treatment & Diagnosis of Lupus

Kelly Tyrrell  |  February 13, 2020

A recent study published in Lupus Science & Medicine lays out five of the top barriers impeding progress in lupus diagnosis and treatment.1 The Addressing Lupus Pillars for Health Advancement project (ALPHA), led by the Lupus Foundation of America (LFA), researchers at the Tufts School of Medicine Center for the Study of Drug Development (Tufts…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:Access to careadherenceBiomarkersclinical trialsheterogeneitySocioeconomic Impact

Arkansas Rheumatology Association Tackles Rural Health Issues

Linda Childers  |  February 13, 2020

In Arkansas, where according to the Arthritis Foundation 672,000 people live with arthritis, it’s not unusual for patients to travel at least 100 miles to see a rheumatologist.1 Michael Saitta, MD, a rheumatologist at the Arthritis Center of the Ozarks, Fayetteville, and president of the Arkansas Rheuma­tology Association (ARA), says patient access is a huge…

Filed under:Professional Topics Tagged with:Access to careArkansas Rheumatology Association (ARA)healthcare accessState Rheum

FDA Rheumatology Update: New Drug Approvals, Plus Expanded Drug Indications & Safety Concerns

Susan Bernstein  |  February 12, 2020

Last year, the FDA was busy with new biologic and other drug approvals, new and expanded drug indications, and important safety updates relevant to rheumatology…

Filed under:Drug Updates Tagged with:2019 ACR/ARP Annual MeetingBiologicsFDAU.S. Food and Drug Administration (FDA)

Pragmatic Language Dysfunction in SLE

Lara C. Pullen, PhD  |  January 20, 2020

A recent study is the first to examine pragmatic language skills in patients with systemic lupus erythematosus (SLE), finding that approximately half of SLE patients have pragmatic language dysfunction…

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:language dysfunctionpragmatic languagesystemic lupus erythematosus (SLE)

New ACR/ARP Committee Members Are Ready to Work

Kimberly J. Retzlaff  |  January 16, 2020

Volunteering is a great way to give back and can be truly meaningful. Myriad worthwhile causes exist, so it can be hard to choose among them, but donating time to ACR and ARP committees helps promote rheumatology practice and brings awareness to rheumatic diseases. The College relies on volunteers to help achieve strategic priorities, promote…

Filed under:Professional Topics Tagged with:Association of Rheumatology Professionals (ARP)LeadershipVolunteering

  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 97
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences